Spinal Cord Stimulation for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
This study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor function.
Will I have to stop taking my current medications?
The trial requires that you do not use analgesics (pain relievers) within 24 hours before the study period. Other medications are not specifically mentioned, so it's best to discuss your current medications with the study team.
What data supports the effectiveness of the treatment Spinal Cord Stimulation for Spinal Cord Injury?
Research shows that combining transcutaneous spinal cord stimulation (a non-invasive method using electrodes to stimulate the spinal cord) with activity-based training can improve upper limb function in people with spinal cord injuries. Preliminary results from a clinical trial indicate that this combination leads to significant and sustained improvements in motor function, even in individuals with severe injuries.12345
Is transcutaneous spinal cord stimulation (tSCS) safe for humans?
How does the treatment of transcutaneous spinal cord stimulation differ from other treatments for spinal cord injury?
Transcutaneous spinal cord stimulation (tSCS) is unique because it is a non-invasive treatment that uses electrodes to stimulate the spinal cord, enhancing motor function and recovery in individuals with spinal cord injury. Unlike other therapies, tSCS can increase the excitability of spinal circuits and facilitate recovery by modulating the spinal cord's neural networks without surgery.123910
Research Team
Ismael Seanez, PhD
Principal Investigator
Washington University School of Medicine
Eligibility Criteria
This trial is for individuals aged 16-65 with a traumatic spinal cord injury between C4-T9 levels, classified as ASIA C or D. They should have difficulty moving their legs independently and be at least one year post-injury. Healthy volunteers in the same age range without major health issues can also participate. Exclusions include severe comorbidities, implanted devices like pacemakers, drug use affecting the study, pregnancy, uncontrolled infections or illnesses that could interfere with exercises.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Short-term Intervention
Participants receive 30 minutes of transcutaneous spinal cord stimulation and/or activity-based training to assess short-term neural excitability changes
Long-term Training
Participants undergo 4 weeks of activity-based training with transcutaneous spinal cord stimulation to assess long-term neural plasticity changes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Activity-based training
- Electrophysiology assessment - corticospinal tract
- Electrophysiology assessment - reticulospinal tract
- Electrophysiology assessment - spinal motoneuron
- Transcutaneous spinal cord stimulation
Activity-based training is already approved in United States, European Union for the following indications:
- Spinal cord injury recovery
- Traumatic brain injury rehabilitation
- Neurological condition management
- Spinal cord injury rehabilitation
- Neurological condition management
- Physical therapy for neurological disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor